SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES) in a report released on Saturday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $3.50 price objective on shares of SenesTech in a research report on Tuesday, May 14th.

SenesTech Stock Up 1.9 %

Shares of SNES stock opened at $0.54 on Friday. SenesTech has a 1-year low of $0.49 and a 1-year high of $11.64. The business has a 50-day moving average of $0.64 and a 200 day moving average of $0.79. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.69 and a current ratio of 6.91.

SenesTech (NASDAQ:SNES) last announced its earnings results on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.02). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The firm had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.43 million. During the same period in the prior year, the company posted ($15.85) EPS. On average, equities analysts anticipate that SenesTech will post -1.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in SenesTech stock. McAdam LLC bought a new stake in shares of SenesTech, Inc. (NASDAQ:SNES) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned about 1.25% of SenesTech at the end of the most recent quarter. 5.19% of the stock is owned by hedge funds and other institutional investors.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.